Kalvista Pharmaceuticals Inc (KALV)
Cours de l'action
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2025-04-11 | 2025-04-09 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
1 000
+0.5%
9,42235 500 USD |
1 000 +0.5% | 9,42 | 100 000 USD | |
| 2025-03-10 | 2025-03-07 | V Vente |
CHIEF EXECUTIVE OFFICER Administrateur exécutif |
6 669
-2.3%
11,9779 828 USD |
6 669 -2.3% | 11,97 | 79 828 USD | |
| 2025-02-25 | 2025-02-24 | V Vente |
CHIEF MEDICAL OFFICER Dirigeant |
2 394
-2.3%
10,0223 988 USD |
2 394 -2.3% | 10,02 | 23 988 USD | |
| 2025-02-25 | 2025-02-24 | V Vente |
CHIEF DEVELOPMENT OFFICER Dirigeant |
1 918
-2.0%
10,0219 218 USD |
1 918 -2.0% | 10,02 | 19 218 USD | |
| 2025-02-19 | 2025-02-18 | V Vente |
CHIEF DEVELOPMENT OFFICER Dirigeant |
2 601
-2.7%
9,8225 553 USD |
2 601 -2.7% | 9,82 | 25 553 USD | |
| 2025-02-19 | 2025-02-18 | V Vente |
CHIEF EXECUTIVE OFFICER Administrateur exécutif |
5 104
-1.8%
9,8250 143 USD |
5 104 -1.8% | 9,82 | 50 143 USD | |
| 2025-02-19 | 2025-02-18 | V Vente |
CHIEF MEDICAL OFFICER Dirigeant |
3 125
-3.0%
9,8230 701 USD |
3 125 -3.0% | 9,82 | 30 701 USD | |
| 2025-02-14 | 2025-02-13 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
61 700
+1.2%
9,33575 661 USD |
61 700 +1.2% | 9,33 | 575 661 USD | |
| 2025-02-14 | 2025-02-12 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
100 000
+2.0%
9,23923 000 USD |
100 000 +2.0% | 9,23 | 923 000 USD | |
| 2025-02-11 | 2025-02-11 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
26 703
+0.5%
9,18245 134 USD |
26 703 +0.5% | 9,18 | 245 134 USD | |
| 2025-02-11 | 2025-02-10 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
4 137
+0.1%
9,1437 812 USD |
4 137 +0.1% | 9,14 | 37 812 USD | |
| 2025-02-11 | 2025-02-07 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
73 649
+1.5%
9,29684 199 USD |
73 649 +1.5% | 9,29 | 684 199 USD | |
| 2025-02-03 | 2025-02-03 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
14 562
+0.3%
9,22134 262 USD |
14 562 +0.3% | 9,22 | 134 262 USD | |
| 2025-02-03 | 2025-01-31 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
11 754
+0.2%
8,89104 493 USD |
11 754 +0.2% | 8,89 | 104 493 USD | |
| 2025-02-03 | 2025-01-30 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
43 707
+0.9%
8,76382 873 USD |
43 707 +0.9% | 8,76 | 382 873 USD | |
| 2024-12-09 | 2024-12-09 | V Vente |
CHIEF EXECUTIVE OFFICER Administrateur exécutif |
7 627
-2.7%
9,7574 363 USD |
7 627 -2.7% | 9,75 | 74 363 USD | |
| 2024-11-27 | 2024-11-26 | V Vente |
CHIEF DEVELOPMENT OFFICER Dirigeant |
1 963
-2.1%
9,8719 378 USD |
1 963 -2.1% | 9,87 | 19 378 USD | |
| 2024-11-27 | 2024-11-26 | V Vente |
CHIEF MEDICAL OFFICER Dirigeant |
2 187
-2.2%
9,8721 586 USD |
2 187 -2.2% | 9,87 | 21 586 USD | |
| 2024-11-19 | 2024-11-18 | V Vente |
CHIEF EXECUTIVE OFFICER Administrateur exécutif |
14 400
-5.1%
9,26133 294 USD |
14 400 -5.1% | 9,26 | 133 294 USD | |
| 2024-11-19 | 2024-11-18 | V Vente |
CHIEF DEVELOPMENT OFFICER Dirigeant |
7 192
-7.4%
9,2666 573 USD |
7 192 -7.4% | 9,26 | 66 573 USD | |
| 2024-11-19 | 2024-11-18 | V Vente |
CHIEF MEDICAL OFFICER Dirigeant |
8 077
-7.9%
9,2674 766 USD |
8 077 -7.9% | 9,26 | 74 766 USD | |
| 2024-09-10 | 2024-09-09 | V Vente |
CHIEF EXECUTIVE OFFICER Administrateur exécutif |
7 352
-2.8%
12,1989 622 USD |
7 352 -2.8% | 12,19 | 89 622 USD | |
| 2024-08-26 | 2024-08-23 | V Vente |
CHIEF MEDICAL OFFICER Dirigeant |
2 135
-2.5%
12,4026 474 USD |
2 135 -2.5% | 12,40 | 26 474 USD | |
| 2024-08-26 | 2024-08-23 | V Vente |
CHIEF DEVELOPMENT OFFICER Dirigeant |
1 916
-2.2%
12,4023 758 USD |
1 916 -2.2% | 12,40 | 23 758 USD | |
| 2024-08-21 | 2024-08-19 | V Vente |
CHIEF EXECUTIVE OFFICER Administrateur exécutif |
14 215
-5.5%
12,01170 769 USD |
14 215 -5.5% | 12,01 | 170 769 USD | |
| 2024-08-21 | 2024-08-19 | V Vente |
CHIEF MEDICAL OFFICER Dirigeant |
7 973
-9.0%
12,0195 782 USD |
7 973 -9.0% | 12,01 | 95 782 USD | |
| 2024-08-21 | 2024-08-19 | V Vente |
CHIEF DEVELOPMENT OFFICER Dirigeant |
7 102
-7.8%
12,0185 318 USD |
7 102 -7.8% | 12,01 | 85 318 USD | |
| 2024-06-10 | 2024-06-07 | V Vente |
CHIEF EXECUTIVE OFFICER Administrateur exécutif |
7 465
-3.2%
11,5386 068 USD |
7 465 -3.2% | 11,53 | 86 068 USD | |
| 2024-05-21 | 2024-05-20 | V Vente |
CHIEF EXECUTIVE OFFICER Administrateur exécutif |
21 959
-9.2%
11,76258 337 USD |
21 959 -9.2% | 11,76 | 258 337 USD | |
| 2024-05-21 | 2024-05-20 | V Vente |
CHIEF DEVELOPMENT OFFICER Dirigeant |
11 610
-12.7%
11,76136 586 USD |
11 610 -12.7% | 11,76 | 136 586 USD | |
| 2024-05-21 | 2024-05-20 | V Vente |
CHIEF MEDICAL OFFICER Dirigeant |
13 175
-15.8%
11,76154 997 USD |
13 175 -15.8% | 11,76 | 154 997 USD | |
| 2024-05-21 | 2024-05-20 | V Vente |
CHIEF SCIENTIFIC OFFICER Dirigeant |
8 088
-10.0%
11,7695 151 USD |
8 088 -10.0% | 11,76 | 95 151 USD | |
| 2024-02-21 | 2024-02-20 | V Vente |
CHIEF MEDICAL OFFICER Dirigeant |
14 295
-21.3%
14,12201 774 USD |
14 295 -21.3% | 14,12 | 201 774 USD | |
| 2024-02-21 | 2024-02-20 | V Vente |
CFO, CBO Dirigeant |
22 802
-10.9%
14,11321 846 USD |
22 802 -10.9% | 14,11 | 321 846 USD | |
| 2024-02-21 | 2024-02-20 | VP Vente planifiée |
CHIEF SCIENTIFIC OFFICER Dirigeant |
300
-0.5%
14,724 416 USD |
300 -0.5% | 14,72 | 4 416 USD | |
| 2024-02-21 | 2024-02-20 | VP Vente planifiée |
CHIEF SCIENTIFIC OFFICER Dirigeant |
19 591
-23.9%
14,04274 991 USD |
19 591 -23.9% | 14,04 | 274 991 USD | |
| 2024-02-21 | 2024-02-20 | V Vente |
CHIEF SCIENTIFIC OFFICER Dirigeant |
8 397
-9.3%
14,11118 522 USD |
8 397 -9.3% | 14,11 | 118 522 USD | |
| 2024-02-21 | 2024-02-20 | V Vente |
CHIEF DEVELOPMENT OFFICER Dirigeant |
12 053
-14.2%
14,11170 124 USD |
12 053 -14.2% | 14,11 | 170 124 USD | |
| 2024-02-21 | 2024-02-20 | V Vente |
CEO Administrateur exécutif |
24 888
-10.5%
14,11351 289 USD |
24 888 -10.5% | 14,11 | 351 289 USD | |
| 2024-02-16 | 2024-02-14 | V Vente |
CHIEF DEVELOPMENT OFFICER Dirigeant |
39 886
-37.6%
15,01598 661 USD |
39 886 -37.6% | 15,01 | 598 661 USD | |
| 2024-02-16 | 2024-02-14 | V Vente |
CFO, CBO Dirigeant |
40 855
-20.4%
15,01613 205 USD |
40 855 -20.4% | 15,01 | 613 205 USD | |
| 2024-02-16 | 2024-02-14 | V Vente |
CEO Administrateur exécutif |
58 356
-24.3%
15,01875 883 USD |
58 356 -24.3% | 15,01 | 875 883 USD | |
| 2024-02-16 | 2024-02-14 | V Vente |
CHIEF SCIENTIFIC OFFICER Dirigeant |
28 171
-28.2%
15,01422 827 USD |
28 171 -28.2% | 15,01 | 422 827 USD | |
| 2024-02-08 | 2024-02-08 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
29 747
+0.6%
14,70437 281 USD |
29 747 +0.6% | 14,70 | 437 281 USD | |
| 2024-02-08 | 2024-02-07 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
51 827
+1.1%
14,56754 601 USD |
51 827 +1.1% | 14,56 | 754 601 USD | |
| 2024-02-08 | 2024-02-06 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
4 474
+0.1%
14,7465 947 USD |
4 474 +0.1% | 14,74 | 65 947 USD | |
| 2024-02-05 | 2024-02-01 | VP Vente planifiée |
CEO Administrateur exécutif |
700
-0.6%
16,8111 770 USD |
700 -0.6% | 16,81 | 11 770 USD | |
| 2024-02-05 | 2024-02-01 | VP Vente planifiée |
CEO Administrateur exécutif |
9 300
-7.3%
16,18150 428 USD |
9 300 -7.3% | 16,18 | 150 428 USD | |
| 2024-02-01 | 2024-01-30 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
88 099
+1.9%
14,471 274 793 USD |
88 099 +1.9% | 14,47 | 1 274 793 USD | |
| 2024-01-29 | 2024-01-29 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
80 600
+1.8%
14,221 146 132 USD |
80 600 +1.8% | 14,22 | 1 146 132 USD | |
| 2024-01-29 | 2024-01-26 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
4 174
+0.1%
12,9854 179 USD |
4 174 +0.1% | 12,98 | 54 179 USD | |
| 2024-01-29 | 2024-01-25 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
7 030
+0.2%
12,7389 492 USD |
7 030 +0.2% | 12,73 | 89 492 USD | |
| 2024-01-24 | 2024-01-24 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
20 686
+0.5%
12,44257 334 USD |
20 686 +0.5% | 12,44 | 257 334 USD | |
| 2024-01-24 | 2024-01-23 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
10 897
+0.2%
12,54136 648 USD |
10 897 +0.2% | 12,54 | 136 648 USD | |
| 2024-01-24 | 2024-01-22 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
67 546
+1.5%
12,55847 702 USD |
67 546 +1.5% | 12,55 | 847 702 USD | |
| 2024-01-19 | 2024-01-19 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
25 000
+0.6%
12,43310 750 USD |
25 000 +0.6% | 12,43 | 310 750 USD | |
| 2024-01-19 | 2024-01-18 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
39 680
+0.9%
12,51496 397 USD |
39 680 +0.9% | 12,51 | 496 397 USD | |
| 2024-01-19 | 2024-01-17 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
78 925
+1.8%
12,60994 455 USD |
78 925 +1.8% | 12,60 | 994 455 USD | |
| 2024-01-16 | 2024-01-16 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
19 599
+0.5%
12,73249 495 USD |
19 599 +0.5% | 12,73 | 249 495 USD | |
| 2024-01-16 | 2024-01-11 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
6 647
+0.2%
12,6884 284 USD |
6 647 +0.2% | 12,68 | 84 284 USD | |
| 2024-01-12 | 2024-01-11 | VP Vente planifiée |
Chief Scientific Officer Dirigeant |
22 679
-36.3%
13,03295 514 USD |
22 679 -36.3% | 13,03 | 295 514 USD | |
| 2024-01-10 | 2024-01-10 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
47 700
+1.1%
12,67604 359 USD |
47 700 +1.1% | 12,67 | 604 359 USD | |
| 2024-01-10 | 2024-01-09 | VP Vente planifiée |
Chief Scientific Officer Dirigeant |
100
-0.2%
13,001 300 USD |
100 -0.2% | 13,00 | 1 300 USD | |
| 2024-01-10 | 2024-01-09 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
20 816
+0.5%
12,56261 449 USD |
20 816 +0.5% | 12,56 | 261 449 USD | |
| 2024-01-10 | 2024-01-08 | VP Vente planifiée |
Chief Scientific Officer Dirigeant |
17 221
-21.6%
13,01224 000 USD |
17 221 -21.6% | 13,01 | 224 000 USD | |
| 2024-01-10 | 2024-01-08 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
69 184
+1.7%
12,44860 649 USD |
69 184 +1.7% | 12,44 | 860 649 USD | |
| 2024-01-05 | 2024-01-04 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
41 764
+1.0%
12,11505 762 USD |
41 764 +1.0% | 12,11 | 505 762 USD | |
| 2024-01-05 | 2024-01-03 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
17 605
+0.4%
12,20214 781 USD |
17 605 +0.4% | 12,20 | 214 781 USD | |
| 2023-12-29 | 2023-12-29 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
6 013
+0.1%
12,4975 102 USD |
6 013 +0.1% | 12,49 | 75 102 USD | |
| 2023-12-29 | 2023-12-28 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
471 490
+13.0%
12,505 893 625 USD |
471 490 +13.0% | 12,50 | 5 893 625 USD | |
| 2023-12-29 | 2023-12-27 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
41 514
+1.2%
11,97496 923 USD |
41 514 +1.2% | 11,97 | 496 923 USD | |
| 2023-12-28 | 2023-12-27 | VP Vente planifiée |
CEO Administrateur exécutif |
30 000
-19.0%
12,02360 453 USD |
30 000 -19.0% | 12,02 | 360 453 USD | |
| 2023-11-21 | 2023-11-20 | V Vente |
Chief Scientific Officer Dirigeant |
4 958
-5.8%
8,2340 801 USD |
4 958 -5.8% | 8,23 | 40 801 USD | |
| 2023-11-21 | 2023-11-20 | V Vente |
President, CFO, CBO & Sec'y Dirigeant |
13 008
-10.4%
8,23107 047 USD |
13 008 -10.4% | 8,23 | 107 047 USD | |
| 2023-11-21 | 2023-11-20 | V Vente |
CEO Administrateur exécutif |
14 807
-8.6%
8,23121 851 USD |
14 807 -8.6% | 8,23 | 121 851 USD |